A Panel of Angiogenic Factors for Early Bladder Cancer Detection: Enzyme Immunoassay and Western Blot-Reference-Cited by-同舟云学术

A Panel of Angiogenic Factors for Early Bladder Cancer Detection: Enzyme Immunoassay and Western Blot

Published:2009-03 Issue:3 Volume:181 Page:1353-1360
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Eissa Sanaa¹,Swellam Menha²,Labib Randa Ali¹,El-Zayat Tarek³,El Ahmady Omar⁴

Affiliation:

1. Oncology Diagnostic Unit, Medical Biochemistry Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt

2. Genetic Engineering and Biotechnology Division, Biochemistry Department, National Research Center, Cairo, Egypt

3. Biochemistry Department, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt

4. Urology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference17 articles.

1. Clinical implications of circulating angiogenic factors in cancer patients;Poon;J Clin Oncol,2001

2. Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation;Vineis;Mutat Res,2000

3. Increased serum angiogenin in colorectal cancer is correlated with cancer progression;Shimoyama;Clin Cancer Res,2000

4. Urinary basic fibroblast growth factor is elevated in patients with bladder cancer and benign prostatic hypertrophy;O'Brien;Br J Urol,1992

5. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder;Eliot;J Urol,1997

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating angiogenin/ribonuclease 5 as a diagnostic biomarker for bladder cancer: In-depth analysis from a systematic review and meta-analysis;Clinical Biochemistry;2024-08

2. Diagnostic Performance of Biomarkers for Bladder Cancer Detection Suitable for Community and Primary Care Settings: A Systematic Review and Meta-Analysis;Cancers;2023-01-24

3. THE RELATIONSHIP BETWEEN INTERLEUKIN-13 AND ANGIOGENIN IN PATIENTS WITH BLADDER CANCER;J PHYSIOL PHARMACOL;2021

4. Urinary Angiogenin as a Marker for Bladder Cancer: A Meta-Analysis;BioMed Research International;2021-04-27

5. Bevacizumab as a potential anti‐angiogenic therapy in schistosomiasis: A double‐edged, but adjustable weapon;Parasite Immunology;2020-05-31